215 related articles for article (PubMed ID: 11502187)
1. Membrane binding and self-association of alpha-synucleins.
Narayanan V; Scarlata S
Biochemistry; 2001 Aug; 40(33):9927-34. PubMed ID: 11502187
[TBL] [Abstract][Full Text] [Related]
2. Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta- and gamma-synucleins.
Uversky VN; Li J; Souillac P; Millett IS; Doniach S; Jakes R; Goedert M; Fink AL
J Biol Chem; 2002 Apr; 277(14):11970-8. PubMed ID: 11812782
[TBL] [Abstract][Full Text] [Related]
3. Lipid interaction of alpha-synuclein during the metal-catalyzed oxidation in the presence of Cu2+ and H2O2.
Lee EN; Lee SY; Lee D; Kim J; Paik SR
J Neurochem; 2003 Mar; 84(5):1128-42. PubMed ID: 12603836
[TBL] [Abstract][Full Text] [Related]
4. Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes.
Davidson WS; Jonas A; Clayton DF; George JM
J Biol Chem; 1998 Apr; 273(16):9443-9. PubMed ID: 9545270
[TBL] [Abstract][Full Text] [Related]
5. Alpha-synuclein has a high affinity for packing defects in a bilayer membrane: a thermodynamics study.
Nuscher B; Kamp F; Mehnert T; Odoy S; Haass C; Kahle PJ; Beyer K
J Biol Chem; 2004 May; 279(21):21966-75. PubMed ID: 15028717
[TBL] [Abstract][Full Text] [Related]
6. Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein.
Li J; Uversky VN; Fink AL
Biochemistry; 2001 Sep; 40(38):11604-13. PubMed ID: 11560511
[TBL] [Abstract][Full Text] [Related]
7. Structure of membrane-bound alpha-synuclein studied by site-directed spin labeling.
Jao CC; Der-Sarkissian A; Chen J; Langen R
Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8331-6. PubMed ID: 15155902
[TBL] [Abstract][Full Text] [Related]
8. Defective membrane interactions of familial Parkinson's disease mutant A30P alpha-synuclein.
Jo E; Fuller N; Rand RP; St George-Hyslop P; Fraser PE
J Mol Biol; 2002 Jan; 315(4):799-807. PubMed ID: 11812148
[TBL] [Abstract][Full Text] [Related]
9. Dependence of alpha-synuclein aggregate morphology on solution conditions.
Hoyer W; Antony T; Cherny D; Heim G; Jovin TM; Subramaniam V
J Mol Biol; 2002 Sep; 322(2):383-93. PubMed ID: 12217698
[TBL] [Abstract][Full Text] [Related]
10. alpha-Synuclein-synaptosomal membrane interactions: implications for fibrillogenesis.
Jo E; Darabie AA; Han K; Tandon A; Fraser PE; McLaurin J
Eur J Biochem; 2004 Aug; 271(15):3180-9. PubMed ID: 15265037
[TBL] [Abstract][Full Text] [Related]
11. The synucleins.
George JM
Genome Biol; 2002; 3(1):REVIEWS3002. PubMed ID: 11806835
[TBL] [Abstract][Full Text] [Related]
12. alpha-Synuclein membrane interactions and lipid specificity.
Jo E; McLaurin J; Yip CM; St George-Hyslop P; Fraser PE
J Biol Chem; 2000 Nov; 275(44):34328-34. PubMed ID: 10915790
[TBL] [Abstract][Full Text] [Related]
13. Synucleins in synaptic plasticity and neurodegenerative disorders.
Clayton DF; George JM
J Neurosci Res; 1999 Oct; 58(1):120-9. PubMed ID: 10491577
[TBL] [Abstract][Full Text] [Related]
14. alpha-Synuclein interacts with phospholipase D isozymes and inhibits pervanadate-induced phospholipase D activation in human embryonic kidney-293 cells.
Ahn BH; Rhim H; Kim SY; Sung YM; Lee MY; Choi JY; Wolozin B; Chang JS; Lee YH; Kwon TK; Chung KC; Yoon SH; Hahn SJ; Kim MS; Jo YH; Min DS
J Biol Chem; 2002 Apr; 277(14):12334-42. PubMed ID: 11821392
[TBL] [Abstract][Full Text] [Related]
15. Mutations in the lipid-binding domain of alpha-synuclein confer overlapping, yet distinct, functional properties in the regulation of dopamine transporter activity.
Wersinger C; Prou D; Vernier P; Niznik HB; Sidhu A
Mol Cell Neurosci; 2003 Sep; 24(1):91-105. PubMed ID: 14550771
[TBL] [Abstract][Full Text] [Related]
16. Structural transformation and aggregation of human alpha-synuclein in trifluoroethanol: non-amyloid component sequence is essential and beta-sheet formation is prerequisite to aggregation.
Li HT; Du HN; Tang L; Hu J; Hu HY
Biopolymers; 2002 Aug; 64(4):221-6. PubMed ID: 12115139
[TBL] [Abstract][Full Text] [Related]
17. Engineered alpha-synuclein prevents wild type and familial Parkin variant fibril formation.
Sode K; Usuzaka E; Kobayashi N; Ochiai S
Biochem Biophys Res Commun; 2005 Sep; 335(2):432-6. PubMed ID: 16081040
[TBL] [Abstract][Full Text] [Related]
18. Fluorescence studies suggest a role for alpha-synuclein in the phosphatidylinositol lipid signaling pathway.
Narayanan V; Guo Y; Scarlata S
Biochemistry; 2005 Jan; 44(2):462-70. PubMed ID: 15641770
[TBL] [Abstract][Full Text] [Related]
19. Metal-catalyzed oxidation of alpha-synuclein in the presence of Copper(II) and hydrogen peroxide.
Paik SR; Shin HJ; Lee JH
Arch Biochem Biophys; 2000 Jun; 378(2):269-77. PubMed ID: 10860544
[TBL] [Abstract][Full Text] [Related]
20. Alpha-synuclein oligomerization: a role for lipids?
Welch K; Yuan J
Trends Neurosci; 2003 Oct; 26(10):517-9. PubMed ID: 14522142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
